Full-Body Tumor Response Heterogeneity of Metastatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radiopharmaceutical Therapy

Victor Santoro-Fernandes; Brayden Schott; Amy J. Weisman; Ojaswita Lokre; Steve Y. Cho; Scott B. Perlman; Timothy G. Perk; Robert Jeraj

doi:10.2967/jnumed.124.267809

Research ArticleTheranostics

Full-Body Tumor Response Heterogeneity of Metastatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radiopharmaceutical Therapy

Victor Santoro-Fernandes, Brayden Schott, Amy J. Weisman, Ojaswita Lokre, Steve Y. Cho, Scott B. Perlman, Timothy G. Perk and Robert Jeraj

Journal of Nuclear Medicine February 2025, jnumed.124.267809; DOI: https://doi.org/10.2967/jnumed.124.267809

Victor Santoro-Fernandes

1Department of Medical Physics, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Brayden Schott

1Department of Medical Physics, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Amy J. Weisman

2AIQ Solutions, Madison, Wisconsin;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ojaswita Lokre

2AIQ Solutions, Madison, Wisconsin;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Steve Y. Cho

3Section of Nuclear Medicine and Molecular Imaging, Department of Radiology, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin; and

4Carbone Cancer Centre, University of Wisconsin, Madison, Wisconsin

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Scott B. Perlman

3Section of Nuclear Medicine and Molecular Imaging, Department of Radiology, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin; and

4Carbone Cancer Centre, University of Wisconsin, Madison, Wisconsin

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Timothy G. Perk

2AIQ Solutions, Madison, Wisconsin;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Robert Jeraj

1Department of Medical Physics, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin;

4Carbone Cancer Centre, University of Wisconsin, Madison, Wisconsin

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

SNMMI members

SNMMI Member Login

Individuals

Non-Member Login

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 66, Issue 5

May 1, 2025

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Full-Body Tumor Response Heterogeneity of Metastatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radiopharmaceutical Therapy

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Full-Body Tumor Response Heterogeneity of Metastatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radiopharmaceutical Therapy

Victor Santoro-Fernandes, Brayden Schott, Amy J. Weisman, Ojaswita Lokre, Steve Y. Cho, Scott B. Perlman, Timothy G. Perk, Robert Jeraj

Journal of Nuclear Medicine Feb 2025, jnumed.124.267809; DOI: 10.2967/jnumed.124.267809

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Full-Body Tumor Response Heterogeneity of Metastatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radiopharmaceutical Therapy

Victor Santoro-Fernandes, Brayden Schott, Amy J. Weisman, Ojaswita Lokre, Steve Y. Cho, Scott B. Perlman, Timothy G. Perk, Robert Jeraj

Journal of Nuclear Medicine Feb 2025, jnumed.124.267809; DOI: 10.2967/jnumed.124.267809

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Keywords

treatment response assessment
response heterogeneity
PET/CT
neuroendocrine tumor
peptide receptor radiopharmaceutical therapy
theranostics

Main menu

User menu

Search

Full-Body Tumor Response Heterogeneity of Metastatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radiopharmaceutical Therapy

Individuals

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords